期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effect of dobutamine combined with meropenem on serum BNP, IGF-1, IGFBP-3, TNF-a, IL-6 and hs-CRP in children with congenital heart disease and pneumonia 被引量:1
1
作者 yan-li xie Tao Wang 《Journal of Hainan Medical University》 2017年第12期83-86,共4页
Objective:To study the effect of dobutamine combined with meropenem on serum BNP, IGF-1, IGFBP-3, TNF-a, IL-6 and hs-CRP in children with congenital heart disease and pneumonia.Methods:A total of 70 children with cong... Objective:To study the effect of dobutamine combined with meropenem on serum BNP, IGF-1, IGFBP-3, TNF-a, IL-6 and hs-CRP in children with congenital heart disease and pneumonia.Methods:A total of 70 children with congenital heart disease and pneumonia in our hospital from June 2014 to Octomber 2016 were enrolled in this study. The subjects were divided into the control group (n=35) and the treatment group (n=35) randomly. The control group was treated with dobutamine, the treatment group were treated with dobutamine combined with meropenem. The two groups were treated for 10 days. The serum BNP, IGF-1, IGFBP-3, TNF-a, IL-6 and hs-CRP levels of the two groups before and after treatment were compared.Results: There were no significantly differences of the serum BNP, IGF-1, IGFBP-3, TNF-a, IL-6 and hs-CRP levels of the two groups before treatment. The serum BNP, TNF-a, IL-6 and hs-CRP levels of the two groups after treatment were significantly lower than before treatment, the serum IGF-1 and IGFBP-3 levels of the two groups after treatment were significantly higher than before treatment, and that of the treatment group were significantly better than the control group.Conclusion:Dobutamine combined with meropenem can significantly reduce the serum BNP, TNF-a, IL-6 and hs-CRP levels, improve serum IGF-1 and IGFBP-3 levels of children with congenital heart disease and pneumonia, and it was worthy clinical application. 展开更多
关键词 DOBUTAMINE MEROPENEM Congenital heart disease PNEUMONIA Children BNP IGF-1 IGFBP-3 Inflammatory factor
下载PDF
Effects of operation combined with chemotherapy on MMP-2, TIMP-1, VEGF, NSE, LDH and immunologic function in children with neuroblastoma
2
作者 yan-li xie Li Wang 《Journal of Hainan Medical University》 2017年第23期84-87,共4页
Objective: To study the effects of operation combined with chemotherapy on MMP-2, TIMP-1, VEGF, NSE, LDH and immunologic function in children with neuroblastoma (NB). Methods: A total of 90 children with NB in our hos... Objective: To study the effects of operation combined with chemotherapy on MMP-2, TIMP-1, VEGF, NSE, LDH and immunologic function in children with neuroblastoma (NB). Methods: A total of 90 children with NB in our hospital from January 2014 to January 2017 were enrolled in this study. The subjects were divided into the control group (n=45) and the treatment group (n=45) randomly. The control group was treated with operation for 7 periods;the treatment group was treated with operation combined with chemotherapy for 7 periods. The serum MMP-2, TIMP-1, VEGF, NSE, LDH, IgG, IgA, IgM, IgE and peripheral blood TTL, THL, TSL, NK, CD4+/CD8+ of the two groups before and after treatment were compared. Results: There were no significantly differences of the serum MMP-2, TIMP-1, VEGF, NSE, LDH of the two groups before treatment. The serum MMP-2, TIMP-1, VEGF, NSE, LDH of the two groups after treatment were significantly lower than before treatment, and that of the treatment group after treatment were significantly lower than the control group. There were no significantly differences of the serum IgG, IgA, IgM, IgE of the two groups before treatment. The serum IgG, IgA, IgM, IgE of the two groups after treatment were significantly lower than before treatment, and that of the treatment group after treatment were significantly lower than the control group. There were no significantly differences of the peripheral blood TTL, THL, TSL, NK, CD4+/CD8+ of the two groups before treatment. The peripheral blood TTL, CD4+/CD8+ of the two groups after treatment were significantly lower than before treatment, the peripheral blood THL, TSL, NK of the two groups after treatment were significantly higher than before treatment, and that of the treatment group after treatment were significantly better than the control group. Conclusion: Operation combined with chemotherapy can inhabit the tumor infiltration and metastasis of the children with NB, can improve the cellular immunity function, and it was worthy clinical application. 展开更多
关键词 Operation CHEMOTHERAPY NEUROBLASTOMA CHILDREN Matrix METALLOPROTEIN Tissue inhibitor of metalloproteinase HUMORAL IMMUNITY Cellular IMMUNITY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部